Defibrillation testing is mandatory in patients with subcutaneous implantable cardioverter-defibrillator to confirm appropriate ventricular fibrillation detection

Jean-Benoit le Polain de Waroux, Sylvain Ploux, Pierre Mondoly, Romain Eschalier, Marc Strik, Laura Houard, Bertrand Pierre, Samuel Buliard, Nicolas Klotz, Philippe Ritter, Michel Haissaguerre, Karim Mahfouz, Pierre Bordachar

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)642-650
Number of pages9
JournalHeart Rhythm
Volume15
Issue number5
DOIs
Publication statusPublished - 1 May 2018

Keywords

  • Complication
  • Defibrillation testing
  • Noise
  • Subcutaneous implantable cardioverter-defibrillator
  • Undersensing
  • RANDOMIZED-CONTROLLED-TRIAL
  • THERAPY
  • EXPERIENCE
  • EFFICACY
  • REGISTRY
  • SAFETY

Cite this

de Waroux, J-B. L. P., Ploux, S., Mondoly, P., Eschalier, R., Strik, M., Houard, L., Pierre, B., Buliard, S., Klotz, N., Ritter, P., Haissaguerre, M., Mahfouz, K., & Bordachar, P. (2018). Defibrillation testing is mandatory in patients with subcutaneous implantable cardioverter-defibrillator to confirm appropriate ventricular fibrillation detection. Heart Rhythm, 15(5), 642-650. https://doi.org/10.1016/j.hrthm.2018.02.013